New chalcone derivatives with pyrazole and sulfonamide pharmacophores as carbonic anhydrase inhibitors    
Yazarlar (4)
Doç. Dr. Mehtap TUĞRAK SAKARYA Atatürk Üniversitesi, Türkiye
Halise Inci Gul
Atatürk Üniversitesi, Türkiye
Hulya Akincioglu
Aǧrı İbrahim Çeçen Üniversitesi, Türkiye
Ilhami Gulcin
Atatürk Üniversitesi, Türkiye
Makale Türü Özgün Makale
Makale Alt Türü SSCI, AHCI, SCI, SCI-Exp dergilerinde yayınlanan tam makale
Dergi Adı Letters in Drug Design and Discovery
Dergi ISSN 1570-1808 Wos Dergi Scopus Dergi
Dergi Tarandığı Indeksler SCI-Expanded
Dergi Grubu Q4
Makale Dili İngilizce
Basım Tarihi 02-2021
Cilt No 18
Sayı 2
Sayfalar 191 / 198
DOI Numarası 10.2174/1570180817999201001160414
Özet
Background: Compound containing sulfonamide, pyrazole and chalcone groups are important in medicinal chemistry. They have a wide range of biological activities, including carbonic anhydrase (CA) inhibitory activities. Introduction: Carbonic anhydrase I and II inhibitors are used for the treatment of diseases, such as retinal and cerebral edema (CA I), epilepsy, and glaucoma (CA II). However, the currently available drugs have some limitations or side effects. Thus, there is a need for new drug candidates to overcome these issues. In this study, a series of compounds, (E)-4-(4-(3-aryl)-3-oxoprop-1-en-1-yl)-3-phenyl-1H-pyrazol-1-yl) benzenesulfonamides MS4-MS10, were designed to discover new CA inhibitors using a hybrid approach. Method: Compounds MS4-MS10 were synthesized as shown in Scheme 1, and their chemical structures were confirmed by1H NMR,13C NMR, and HRMS spectra. The CAs (E.C.4.2.1.1) inhibitory effects of MS4-MS10 were tested on the hCA I and II isoenzymes using previously reported procedures. Results: The CA inhibitors MS4–MS10 gave IC50 values (nM) of 27.8–87.3 towards hCA I and 24.4–54.8 towards hCA II while the IC50 values for reference drug acetazolamide were 384.2 (hCA I) and 36.9 (hCA II). MS7 and MS9 exhibited 13.8 (hCA I) and 1.5 (hCA II) times more potent CA inhibition than the reference compound acetazolamide, respectively. Conclusion: MS7 (Ar: 2,4,5-trimethoxy phenyl) and MS9 (Ar: 3,4-dimethoxy phenyl) were the most promising compounds of our series with the lowest IC50 values towards hCA I and hCA II, respectively, and can be considered for further studies.
Anahtar Kelimeler
Carbonic anhydrase isoenzymes | Chalcone | IC 50 | Pyrazoline | Sulfonamides | Synthesis